Individual Patient Compassionate Use of Nirogacestat

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05561036` - A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor	Phase 3
Completed	`NCT00287846` - Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis	Phase 1/Phase 2
Recruiting	`NCT06258421` - Burden of Disease and Living Situation in Desmoid Patients
Completed	`NCT00030680` - Radiation Therapy in Treating Patients With Aggressive Fibromatoses	Phase 2
Recruiting	`NCT06081400` - Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting	N/A
Active, not recruiting	`NCT04871282` - A Study of AL102 in Patients With Progressing Desmoid Tumors	Phase 2/Phase 3
Recruiting	`NCT01567046` - Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas	N/A
Completed	`NCT01137916` - Study to Evaluate Imatinib in Desmoid Tumors	Phase 2
Completed	`NCT00002595` - Toremifene in Treating Patients With Desmoid Tumors	Phase 2
Completed	`NCT03459469` - Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059	Phase 1
Completed	`NCT06195085` - CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors
Completed	`NCT01286662` - A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome	N/A
Completed	`NCT01265030` - A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis	Phase 1/Phase 2
Completed	`NCT00068419` - Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor	Phase 2
Completed	`NCT04289077` - Quality of Life of Patients With Desmoid-type Fibromatosis
Completed	`NCT03190174` - Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers	Phase 1/Phase 2
Completed	`NCT00003019` - Vinblastine and Methotrexate in Treating Children With Desmoid Tumors	Phase 2
Recruiting	`NCT05949099` - Study of Cryoablation and Nirogacestat for Desmoid Tumor	Phase 2
Active, not recruiting	`NCT02076906` - MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors	Phase 1
Completed	`NCT00474994` - Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas	Phase 2

NCT number	NCT05041036
Study type	Expanded Access
Source	SpringWorks Therapeutics, Inc.
Contact	SpringWorks Medical Information
Phone	(888) 400-7989
Email	medinfo@springworkstx.com
Status	Available
Phase

Individual Patient Compassionate Use of Nirogacestat

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms